Lv31
220 积分 2022-10-14 加入
The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
5天前
已完结
Oleuropein mitigates non‐alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high‐fat diet‐induced obese mice via activating PPARα
1个月前
已完结
Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway
2个月前
已完结
Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells
3个月前
已完结
Diabetic neuropathy
3个月前
已完结
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
4个月前
已完结
ALKBH5 knockdown suppresses gastric cancer progression by reducing the expression of long non-coding RNA TUG1
4个月前
已关闭
P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: network pharmacology and experimental validation of multi-target signaling pathways
5个月前
已完结
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
9个月前
已完结
LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability
10个月前
已完结
皖公网安备34019202002308
